Series C Health Diagnostics Companies

Iterative Health develops technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.

Ultromics develops AI-driven cardiology solutions to assist in cardiovascular disease diagnosis through echocardiography.

GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.

Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.

Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.

Nusano is a physics firm that produces radioisotopes, tiny tracers doctors use to diagnose and cure cancer and other ailments.

Heartbeat Health is a digital health company that utilizes technology to improve cardiovascular disease prevention and management.

Onera Health is a global leader in sleep diagnostics and monitoring.

4D Lifetec is a biotechnology company promoting and developing screening and test systems for molecular diagnostics.

MitrAssist offers a minimally invasive approach to mitral regurgitation treatment.

IBEX is a Medical technology manufacturer that develops AI-powered diagnostic solutions to help pathologists.

Diality is a medical device company developing solutions that improve lives impacted by kidney disease.

RapidAI empowers clinicians to make accurate diagnostic and treatment decisions for stroke and aneurysm patients.

KIYATEC utilizes the patient's own living tumor cells to create functional 3D models to test a battery of cancer therapies.

4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment of Circulatory Shock.